Patents/Assignees

Revolution Medicines, Inc.

32 patents in portfolio

US11739093utility2023
Substituted Pyrazolopyrazines, Imidazopyrazines and [1,2,4]triazolopyrazines as Allosteric SHP2 Inhibitors
0 cites
US11702411utility2023
Pyridine, Pyrazine, and Triazine Compounds as Allosteric SHP2 Inhibitors
0 cites
US11690915utility2023
Ras Inhibitors
0 cites
US11685749utility2023
C26-linked Rapamycin Analogs as Mtor Inhibitors
0 cites
US11673896utility2023
Pyridine Compounds as Allosteric SHP2 Inhibitors
0 cites
US11673901utility2023
Polycyclic Compounds as Allosteric SHP2 Inhibitors
0 cites
US11661401utility2023
2,5-disubstituted 3-methyl Pyrazines and 2,5,6-trisubstituted 3-methyl Pyrazines as Allosteric SHP2 Inhibitors
0 cites
US11644460utility2023
Identifying New Therapeutic Agents
0 cites
US11634435utility2023
Polycyclic Compounds as Allosteric SHP2 Inhibitors
0 cites
US11608346utility2023
Ras Inhibitors
0 cites
US11596633utility2023
SHP2 Inhibitor Compositions and Methods for Treating Cancer
0 cites
US11566007utility2023
Ras Inhibitors
0 cites

← PreviousPage 2 of 2